Are you watching robotics stocks? Because you should be in 2026.

The American robotics industry is experiencing a truly special moment. It’s no longer just lab work or experimental prototypes; robots have really entered the key sectors: healthcare, manufacturing, logistics. And investments are following this trend.

During the early 2026 CES, Jensen Huang of Nvidia practically declared that robotics has reached its 'ChatGPT moment.' This isn’t just a throwaway phrase. In 2025, global investments surpassed $10.3 billion, the highest since 2021. AI figures alone raised over a billion dollars at a valuation of $39 billion. That’s the kind of capital you see when a sector is about to explode.

Market numbers are impressive. Medical robotics are expected to grow from $18.32 billion in 2026 to $72.54 billion by 2035, with an annual growth rate of 16.62%. Humanoid robots? CAGR of 39.2%. The overall global robotics market will aim for $124.37 billion. These aren’t random numbers; they are drivers of structural growth.

As for specific robotics stocks, the companies leading the movement are interesting. Intuitive Surgical saw da Vinci procedures grow 18% in 2025, and the FDA approved the da Vinci 5 for nine cardiac procedures in January. Banner Health upgraded all 49 of its systems to the new model in February. This is real momentum, not just hype.

Teradyne is expanding aggressively. It opened a new operational hub in Michigan, USA, and its Universal Robots brand showcased new palletization solutions at CES. Nearly 50% of small and medium-sized American manufacturing companies now use collaborative robots, up from 27% two years ago. The ROI? Generally within 12-36 months.

Nvidia has positioned itself as the central platform for physical AI. It launched the foundation model Isaac GR00T N1, the open-source physics engine Newton, and the Jetson T4000 module. With over 250,000 developers on its robotics platform, it’s in a unique position for the next wave of intelligent machines.

Trimble, on the other hand, is building its business on positioning-based robotics. It powers autonomous systems like Lucid Gravity and is integrating Boston Dynamics’ Spot robots for autonomous construction site scanning. This kind of diversification works well in the robotics sector.

There are also developments in the medical field. Medtronic received FDA approval for its Hugo system in urological procedures, and Johnson & Johnson filed for Ottava in general surgery. This intensifies competition but also broadens the market.

Elderly care robotics is another growing area. The market will grow from $3.38 billion in 2025 to $9.85 billion by 2034, with a CAGR of 14.2%. Population aging is a structural driver that isn’t going away.

Of course, there are challenges. US-China tariffs are increasing component costs, but they’re also pushing investments into domestic supply chains. The US Army introduced a specialization for AI and machine learning officers in January, and the Pentagon’s $13.4 billion budget for autonomous systems shows that robotics is not just a commercial game.

What’s interesting about robotics stocks right now is that private capital and political authorities are finally aligned on a national strategy. The Association for Automation Advancement has invited the Trump administration to implement a national robotics strategy. When you see this level of coordination, you know the trend is serious.

So, if you’re looking where to focus in 2026, the robotics sector has the fundamentals for an interesting year. It’s not speculative volatility; it’s structural growth supported by real data and massive investments. The robotics stocks leading this transition could offer significant opportunities in the coming months.